OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Legal and administrative Informatlon Trustees Dl8go du Monceau de Bergendal Duncanjodrell CarollneArtIs Re0stered offlee 49 Stjames s Street London SWIA IAH Re8lster•d number 272818 Chartor￿1 accountsnl Melissa Foux nr8313878 $6 Fianders Road Londtsn W4 ING Bankers Coutts&Co 440 Strand London W¢2ROQS

Trustee's report 31 December 2025 The Trustee5 present thelr report along with the accounts of the Frlends of EORTC Ithe Charity) for the year ended 31 December 2025. The accounts have been prepared in accordance with the accountlng polkies set out on pages 16 to 18 and complywith the charity's trustdeed, the CharitiesAct 2011 and'Accounting and Reporting by Charities.. Statement of Recommended Practice applitable to charities preparing their accounts in accordance with the Flnancial Reportin8 Standard applicable In the United Kingdom and Republic of Ireland {FRS 1021. Strurturep governance and management The Charty was established under a Trust Deed In 1976 and is registered with the Charfty Commission under charity number 272818. The Chairman. Comte Diego du Monceau de 8eTgendal, was appointed a trustee in 2015 on the retirement of the then Chairman, Sir Christopher Mallaby. His fellow trustee, Lady Solti was apk)ointed a trustee in 1998, and Mr Edward Chandler was appointed on 7 October 2020, coinciding with the resignation of Mrs Victoria Agnew who had dedicated 22 years to her role with the organisation. Pr. Duncan Jodrell was appointed on 10 November 2021 to replace Lady Solti. Mrs Caroline Artis was appointed on 7 October 2022. Mr Edward Chandler resigned on March 1, 2023. There 15 no time limit on the tenure of the trustees. The trustees meet twice a year. The Board keeps the Skill requirements for t￿ Trustee Body under review and if a trustee permanently retlres or addhional trustees are required, the Board would put in place appropriate procedures to recruit the new trusteelsl. The Board would 3150 ensure that appropriate induction and trainln£ is provided to all new trustees. Statement of trustees, resp¢nsibilities The trustee5 are responsible for preparing the trustee5' report and accounts In accoidance with applicable law and United Kingdom Accounting Standard5 Iunlted Kingdom Generalty Accepted Accounting Practice). The law applicable to char6tles in England and Wales requires the trustees to prepare accounts for each fiscal year whlch 86ve a true and fair view of the state of affairs of the charlty and of the incoming resources and applicatlon of resources of the charity forthat perlod. In preparing these accounts. the trustee5 are requlred to.. select suitable accounting policies and then apply them consistently.. observe the methods and principles in the Charities SORP,. make judgements and estimates that are reasonable and prudent; state whether applicable UK accounting Standards have been followed, subject to any materlal departures disclosed and explained in the accounts,. and prepare the accounts on the going concern basi5 unles5 It is inapproprlate to presume that the charty will continue in operation. The trustees are responsible for keeping proper accounting records that disc105e with reasonable accurary at any time the financial position of the charity and enable them to ensure that the accounts comply with the Charities Act 2011. the Charity IAtcount5 and Reportsl Regulations 2(K)8 and the provisions of the trust deed. They are also responslble for safeguarding the assets of the charlty and hence for taking reasonablè step5 for the prevention and detettion of fraud and other irregularities. Rlsk management The Charity does not hève any employees. significant contracts or material investments nor is the Charitv dependent on grant fundlng from external sourtes to rnaintsin its charitable attivities. As a result of these limited activities, the Charlty is exposed to lew slgnificant risks. The prlntipal risk faced by the Charity would be the fallure to generate suffident donations to cover the costs of or8anising a fundralsing event. This is mStigated by the Charlty, wherever posslble, by raising fund5 In advance of costs being incurred,. carefully planning its

fundraising events,. targetlng known supporters of the Charity and closely monltoring fundraising tosts and donations. Objectives and Acti¥rtles EORTC was set up in 1962 by leadin8 cancer specialists in the EU and Swltzerland In order that research on treatment of cancer could be co-ordinated and carried out on a European scale, thereby avolding duplScation and achieving economies of time and money. The primary objert rif the Charlty. as stated In Its goveming dotument, is to support the chadtsble objects and purposes of EORTC Can￿r Research Fund AISBL IECRFI, a charity registered in Belgium. The ECRF was estsblished in 1976, as The EORTC Foundation. Thls charitable trust was established to support the artivities of the EORTC. The ECRF supports the activities of the EORTC through annual grant payments to the EORTC which are used by the EORTC to fund researth into cancer treatments. The Frlends of EORTC sUPPOrts the ECRF by organising fundraislng events in the UK and by a malor fundraisin8 initiative. The funds raised by the Frlends of EORTC are then used to support the activities of the ECRF. The Friends of EORTC makes donations to EORTC on an ad- hoc basis, as determined by the Trustees. Achlevements and Performance Finan¢lal revlew The Income of the charty declined over that of the previous year. however a major fundraislng initiative continued, and private donations were received In 2025. The charity received donations from its supporters mountinE to £154,83612024- £40,1221. Total expenditure.. £ 152,62812024- £ 42,0571. The charfjty remains financially stable with a small surplus. Interest and forel8n exchange The Charity earned £245 in interest In 202512024-£5571 and booked no foreign exchange gains12024- none). The Boots Group* TBG Ifonnerly known as Walgreens Boots Alllance, WBA} EORTC Cancer Research Fund Iformerly the EORTC Charitable Trust) has been in partnership with The 800ts Group (formerly WBA, then Alliance Boots) Since late 2011. The partnership focused on creating the first pan- European biobank In advanced colorectal cancer, now fully operational in Dresden. Formerly known WBA commltted to raislngC5 million Dver five years to supportthis key research infrastructure. Sclentific planning for the project, named SPECTAcolor, began in 2012 with the development of biobanking facilities and identification of partlcipatlng hospitals. The success of SPECTAcolor led EORTC to expand to other cancer types, culmlnatinÉ In 2018 with the launch of SPECTA. a unified platform for all cancers, including rare ones, with a central bSobank in Luxembourg. That same year, the Group renewed its 5UPPOrt through a new £5 million. five-year agreement, reaffimiln8 SPECTA'S position as a leading translational research infrastructure In Ortober 2022, the Group and EORTC launched a new three-yearfundraising effort to raise (1.8 milllon for the OligoRARE study and the E -RADlatE platfomi. which alms to define optimal radiation theropy practices for future c15nical standards. E'.RADlatE is the only p?n-European platform dedicated to radiation oncolobry research, integrating clinlcal data with diagnostic imagin& treatment data, economic outcomes, and patient-reported experiences to enhance patient-centred ca￿.

The platform indudes several obseryational cohort studies and clinical trlals: Ollgocare IEORTC 1822-RPI.' the first attivated cohort. focuses on patients with oligometastatic disease (cancer spread to 3 limlted number of organs). aiming to identify factors influencing SLtrvival after radical radiotherapy. Cancer types studied include breast, lun& prostate, and colorectsl. Recaie IEORTC 2011-RPI.' collects real-world data on hlgh-dose re-IrradiatSon in cases of recurrence or secondary cancers. It aims to provide evidence on efflcacy and Safety of re-treatment in the modern radiotherapy era. Oli8oRARE IEORTC 19451.. a randomized clinical trial evaluatin8 whether SABR (Stereotactic Ablative Body RadSotherapyl Improve5 survival ￿mpared to standard care in patients with oligometastatlc rare cancers. SPRI?￿ IEORTC 23871- 15 the first pan-European Trial wlthin Cohorts ITwiC51, leveraging real-world data from the ol1goca￿ cohort to evaluate treatment strategies for patients wlth ollgometa5tatic breast, prostate. lung, and co10￿cta1 cancers. The study aims to determine whether a single fraction of stereotartic body radiotherapy ISBRT) can be as effective as multl-frattion SBRT. potential￿ reduclng treatment burden vA)ile improving patient experience and quality of lrfe. E -RADlatE Supports radiOtherap￿S role as a cornerstone of carkcer care, used by half of all patients during treatment. 8y leveraging advanced technology and structured dats collectlon, the platform contributes to re(luclng inequities in ¢are and Improving outcomes across Europe. Alllance HealthcaTe (to be renamed Cen¢oral In June 2021, Walgreens Boots Alllance sold its Alliante Healthcare businesses to Amerlsource8ergen, now renamed Cencora. Alllance Healthcare. now a wholly owned subsldiary of Cencora. supported the SPEcfA platform under its new ownership with half of the Initial pledge be raised by the end of the agreement in 2023. In 2024, Cencora contrlbuted an additional SIOOK towards the plarform. The funds raised through the partnership are estimated to cover the current artivitles of the platform until 2027. In 2025, with the departure of Mrs Barra from the Cencora Board, ECRF recefved a donation of $5,OW in honour of her seNices to their Board. The fund5 were allocated to E2-RADlatE ￿lating activities. Alliance Healthcare (soon to be renamed Cen¢ara) contributlon5 From June 1st, 2021, to December 2024. 2023, Alliance Healthcare has raised a total of Q,192,401.24. Honouring the origlnal agreement between the former WBA and EORTC. AMRC- Assoclatlon of Medical Research Charltl Since October 2014, the Friend5 of EORTC has been a member of AMRC. This membership provides tlear benefit5 for EORTC and for the costs related to its intemational clinical studies belng opened or adopted in the UK. Membership of AMRC laudlted on an annual basis) helps the EORTC to quallfy as ellgible under the UK NHS ACORD Programme under whlch certain clinical research costs are met by the National Health Service. Under ACORD, AMRC charitle5 that fund In open competition do not have to pay these costs. The work will be done by the NIHR Clinical Research Networks or will be covered by the infrastructure 5UPPOrt funding golng to NHS trusts and universities. EORTC, through the Friends of EORTC. is in good stsnding for supportfrom the NIHR and NHS for other study related costs as described above. UK Llalson Office A Liaison Office has been established in the UK between the Natlonal Cancer Research Institute INCRII, EORTC and CR-U¥ to promote better communications between these three organisations and to facilltate the adoption of EORTC'S international studies in the UK and the extension of UK Studies Into Europe. The Friends of EORTC supports this initlative by currèntly contrlbuting one thlrd of the costs of the salary of the Lialson Officer, based at the University of Leed5. Since 2017. the costs of the Liaison Office in Leed5 have been shared bètween EORTC and CR-UK.

Investment powers. polky, and pertormance The Charity does not hold investments other than cash held on an interest bearrng deposlt on a short-term basis. These funds are held in the Charity'5 bank account, held by Coutts. Grant makln8 pollry The Charity makes grants to the EORTC and to the EORTC Cancer Research Fund and for fellowships, a5 dlrect rants or on an ad-hoc basls. Reserves The Charity makes grants to the EORTC as cash becomes available, retainin8 sufficient funds to tover the potential outgoings associated with future fundraising events. The Charity does not enter on-going commitments and therefore does not need to ensure a steady flow of income. For this reason, the trustee5 do not consider it appropriate to maintain a target level of re5etves. The fvnds ralsed by the Charity are held as deposlts on call accounts until such time that the Trustees wish to make grants or donations directly to the EORTC to support their ongolng activities. Golng concern The Trustees of the charity have detemiined that there are no materlal uncertainties related to events or conditlons that may cast significant doubt on the abllity of the tharity to continue as a going concern. The trustees are of the opinion. based on avallable information at the date of approval of the financial statements. that the charity woll have su)Ticient ￿$0￿r(est0 meet its liabilities asthey fall due. They do not believe thattherè are concerns regardlng the charlty's abilty to continue as a going concern. Approved by order of the Trustees Chairman Die80 du Monceau 0111012026 Date

Ind•p•ndont oxamln•r* r•port to th• lrn8ts•8 ofth• Frl•nd8 of EORTC I report to the trustee8 on rny examlnatlon of the accounts of the Frlends ot EORTC for the year ended 31 December 2025. Ro•ponJlblUtIM and ba8ls of r•pon A3 the charity trustees of the Trustyou are responslble lorth8 preparatlon of the accounts in accordance wlth the requlrements otthe Charftles Act 2011 {'the Acf). l report In respect of my exemlnatlon of the Tru8t s accounts carrfed out under sectlon 145 of the 2011 Act end in carrying out my ex8minatlon I have followed ati the 8ppIIc8bie Dlrèctlons glven tythe Charltyccmmlsslon under8ectlon 145{5)(b) oftha Ind•pondent oxamln•rts 8tat•m•nt. I completed my exarnln8tlon. I conflrm that no m8t8rial matters have come to my attention In connectlon wlth the examlnatlon 8lvlng me cau80 to beueve that In ary materlal respect: 1. 8ccountlng record8 were not kept In respect of the Trust 88 required ty section 130 01 the ACL. or 2. the accounts do not accord with those records: or 3. the accounis do not compty wlth the appllcable requSrements eoncernlngthe form and content of accounts set out Sn the Charities (Accounts and Report8) Regulatlons 2008 otherthan any requlrement thatthe accounts give a ?rue and fair vlewwhlch18 not a matter consldéred a8 part of an independent examlnatlon. I have no concems and have come across no other matter8 In ¢onne¢tlon wlth the &Yamination to whlch attention should be drawn in thls report in order to enable a proper underst8ndlng of thè accounts to be reached. Signed." Name: Melissa Foux Relevant professlon81 quaifflcatlon or membership of professlonal bodies (if any): Chartered Accoumant ICAEW Membership number 8313878 Addre$8.' 56 Flandern Road London W4 1NG Date: 0111012026

ststement of financlal activltles Year ended 31 December 2025 2025 Total funds 2024 Total funds Unrestrktsd fvnd5 Restricted funds Notes Income: Donatlons Bank interest Total Inrom• 53,486 245 53,731 101.105 154591 24 154,836 39,565 557 40.122 101.105 Expendture". Expendltvre oft charltsble artI￿tIeS Totsl •xpenditur• 152 628 IS2M8 56.523 96,105 42.057 Ilet ineome {eMpendlture} Net movement In lunds 5,000 Recondll*lon of funds: Funds brought fonvard at l January 2024 17,836 17 19,777 Funds orrled forward at 31 December 2014 15,044 20O50 17,842 All ofthe above amounts resulted from the tharity'$ contlnulng act￿ltIeS durlngthe abover two financial perlods, The notes on pages 19 to 22 form part of these accounts

Balance sheet 31 December 2025 2025 2024 Notes c￿￿ent assets: Debtors Cash at bank In hand 53,786 30.842 76.651 49.797 Uabllltles: Credltors: amountsfalling due withln oneyear -56.600 -31.9S5 Total net assels 20,051 17,842 Thefunds otthe ¢harltr. Restrfcted funds Unrestricted funds General funds Totalfunds 20.051 17,842 The note5 on pages 19 to 22 fom) part ofthese accounts

Statement of cash Ilows 31 December 2025 2024 Note5 (￿h Ilowslrorn operat1nzad1￿I1È￿'. Netcash provlded by operating actsvitles 3.665 40,￿$ Bank Interestod receNed 24 557 Ch•ny In ¢a5h andrashequWThts Ihtheyt•r 3.910 -39.528 Cash and ￿5h equfvalentat lJanuary1025 495S 58,483 ¢h ahd Gjsh ¢qW¥w￿￿t4t$I I)e￿mber1025 2l865 1&955 Notss toth•¢•gh)lowststementforthe y•ar to Yi Deumb•r2014 A RewThtlM•tlon of thet mo¥em•rt In fund5 lo Tret ta5hllrbwfrom x 2024 mo¥emÈr>tin fundslas perstaremtnt offinantvdl att￿￿Es) Intere$t receivablè Decrease/llnerÈasel debtors IDKrea5el in crtdkor5 N•tush ￿￿e0 byo r•tknEacthAdes -L935 -557 11.587 3,665 An11￿&01￿3￿*s1n netd•èt All January 2025 At han#e Deumbw Year 21)25 Cash at bank ahd in hand 18,955 3.910 32,865

Principal accouting policies 31 December 2025 Basls of pieparatlon The princlpalaccountlng policies adopted* judgements and keysources of estlmatlon uneertainty in the preparation of the linanclal statements are laid out below. 8asls of accountlng These accounts have been preparedforthe yearto 31 December 2025. The accounts have been prepared underthe historlcal cost convention wth items initlally recognise(J al cost ortransactionvalue unless Othemise stsied in the relevant accountlng pollcles below or the note5 to these accounts. The accounts have been prepared In accor(lance wlth Accounting and Reporting by Charltles: Statement ol Recommended Practlce applicable to charities preparingtheir accounts In accordan¢e with Ihe Financial Reportlng Standard appllcable in the UKand Repubilc of Iieiand IFRS 1021 I'charitles SORP FRS 102,1 issued on 16 July2014, the Flnancial Reporting Standaid applicable in the un￿e￿ Kingdom and Repubilc of Ireland IFRS 1021 andthe Charftles Act 2011. The charfty constltute5 a pubife benefit entityas defined byFRS 102. The accounts are presented in stertingand are rounijed to the nearest pound. Crltlcal accountinge$timates and area$ of lud8ement There are no items In ihe accounts %there Irustees have been requlred to make signilicantjudgements an¢J estimates. Assessment of golngcon¢ern The trustees have assessed whether the use of the golng concern assumption is approprlate In preparingthese accounts. The trustees have made this a$sessment in respect lo a perlod of one year from the date of approval of these accounts. The trustees of the charlty have concluded that there are no materlal uncertalntles related lo events or conditions that maycast slgnlflcanl doubt on the abiL4tyof the charltylo contlnue as a goingconcern. The trustees are of the opbnlon that the charity will have sufficient resources to meets rts liabilities as they fall due. In makingihis assessment, tiustees have considered the impact of the coronaviw5 pandemic on the operatlonal and financial performance ofthe charity. Funds struclure Unre5tr1cted Income funds are those whlch the Trustees arefree to use for any purpose In furtheiance ol the charitys objects. Unrestricted funds include designated funds, where the donor has made known their non binding wishes orwhere the trustees èttheii discretion, have created the designatlon lor a specific purpose, Restricted lun(Js arise from grants and donations recelved for specific purposes definèd by the donor orthe terms of an appeal. Restricted funds relatingto Income received In connection with the Aiilance Boots Blobank project are llanslerred to the Biobank projectlhrough grants made to the EORTC.

Principal a¢coutin8 policles 31 December 2025 Incom8 All incoming iesources are recognised when the foiLowingihree factors are met". l. entitlement-conlrol over the righttolhe economic beneflt has passed to the charity. 2. probable- it15 more likelythan nol thatthe economlc benefits associated wlth the transaction wlll flow to the charlty. 3. measurement- when the monetaryvalue of the incomlng resources can be measured retlably. Income comprises donations and bank interest. Donations are recognised when the charfty has confirmation of both the amount and settiementdate. Inteiest on funds held on deposit is Included when ieceivable and the amount can be measured rellably by the charlty.. this Is normally upon notification of the interest paid or payable bythe bank. Forelgn exchange Item5 appearing in the accounts have been translated on the followlng bases: Assets and liablllties- at rates prevailing atlhe balance shget date. Income and expendlture.. at average rates forthe year. Differences arislng on exchange are Charged or credlted to the Statement of FinancialActMties. Expendllure Liabilttles are recognlsed as expendltltre as soon as there Is a Legal or constructwe obligatlon commtttlng the charityto make a paymentto a Ihird pèty, it is probable that a transfer of economic benefits wlll be requlred in settlement and the amount of the obligation can be measured reliably. All expendlture is accounted for on an a¢ciuals basls. Expenditure comprises direct Costs aniy support costs. Ail expenses, including support costs. are allocated or apportioned to the appllcable expenditure headings. The classificatton between activities Is as follows: - Expendlture on raislnglunds Includes all expenditure associated wlth raislngfunds forlhe charity Expendlture on charitable activities includes ali costs assoclaied wlth furtherlngthe charitable PUTposes of the charltythrough the pYovi5ion of Its charftable actrvltles. Such costs include chaiiiabie grants and donations, direct and support Costs and govemance costs. Grants are made to the EORTC and to the EORTC Cancer Research and forfellowshlp5. A Ilabiutyfoi such grants is recognised when approval has been given bythe frustees.

Prlncipal accoutln8 policle5 31 December 2025 Expendlture {contlnued} Other¢05ts includes all expenditure that cannot be analysed into the abovetwo headlngs. Contractual arrangements are recognised as goods and Ser￿CeS are supplied and ale accounted for on an accruals basis. IrrecoverableVAT Is charged agalnstthe category ot resources expended, forwhich It was Incurred. Deblorg Debtors are recogni$e(J attheir settlèment amount. less any provision for n0n-recoverabl1￿. Prepayments are valued at the amount Prepaid. Cash at bankand in hand Cash at bankand in hand represents such accounts and instwments that are available on demand or have a maturlty of less than thTee month5 from the date of acquisltlon. Deposits for more than three months but less than one year have been disclosed as shor( term deposits. Cash placed on deposil for more than one year is disc105ed as a fixed asset Investment. Credltors and provlslons Creditors and prO￿S1On5 are recognlsed when there is an obligation at the balance sheet date as a result of a past event. ￿ Is probable that a transfei of economic benefit will be required In seittement, anl the amount ofihe settlement can be estlmated ¥eliably. Creditors and provlslons are recognlsed at the amountthe charltyantlclpate5 Itwlll payto settiethe debt.

Notes to the a¢counts 31 December 2025 Relatod partytr•wettotts The Friends of EORTC provides finzncial supwjrtto the EORTC Cancer Researth Fund and EOftTC. The Trustees tsf the Charity had tho followin8 connection5 wfth these orBanlsafjonihrou8hout 2022 and 2025. EORTtCantet fte5￿h Fund Chairman Of1￿ Counell Memberof thecoundl Memberofthe Coundl Diego dv Monreau de 8ergendal Duntan Jodrell Cèrollne knis EORTC Board member Board member Grants to EORTC are sh¢)wn In thote 3 below. None of the tDJ5tee5 recefved paymerf forthelrsÈrvtw tothe (harity or relmbutsement of expense5 bythe Chathv. Donatlon% Unre￿ricted f¢Jnds R•strfcted tknnations from ind￿ldUal$ andlovndatlons Corp)rate donafjDns 2025total funds loo￿(￿) 153486 1,105 1.105 101.105 154,591 53.486 UnrestrKted fund5 Restrlcted funds 2024 Donations from IndNiduals and foundatbn5 Corporate don0￿0￿5 2025 totsl funds 39.529 39529 36 36 39.529 19,565 Chirlt•ble expenditur• Unrestricted Restrkred funds fund5 Grants awarded U?ison office and finance costs Bad debt expense 96.105 96.105 53A41 53.442 G¢>vernance costs Audit and accountingfres Rentsl B•n* and subscription char8es 2025 totsl funds 1.2(M) 1.281 56523 96,105 151618

Notes to the accounts 31 December 2025 3 Charltable expendlturÈ Icontinuedl Unrestricted funds Restricted funds 2024 Dlrect t05ts Grants awarded Liaison office and finance costs Bad debt expense 36 36 39A79 39,479 Support costs Governance costs Audit and accounting fees Bank and subscrlption charges 2024 total funds 1,21 1,342 42,021 L200 1,342 42,057 36 There are no key management personnnel employed by the charity. 4 Comparatlve Statement of Flnanclal Actlvftles Unrestricted Unrestricted funds Restrlcted funds 2024 Notes Income: Donatlons Bank Interest Total income 39,529 557 40,086 36 39,565 557 40,122 36 Expenditure., Expenditure on tharitable activitie5 Total expenditure 42,021 42,021 36 36 42,057 42.057 Net income lexpendlturel -1,935 -1.935 Net movement In funds -1.935 -1,935 Reconciliation of funds.. Funds brou8ht forward at l January 2024 19.771 19.777 Funds carried forward at 31 December 2024 17,836 17.842 5 0ebtOfS 2025 2024 Prepayments and other debtors Gift Aid 53,786 30.842 53.786 30,842

Notes to the accounts 31 December 2025 6 Current Ilabilltles 2025 2024 Amounts failin8 due within one year: Accruals Debt EORTC Trade credltors 2,343 816 53,441 56.600 31,955 31,955 7 Re$trlrted funds The Income f(nds of the charity include ￿StrIcted funds comprising the following unexpended balances. Ati At31 January Incomlng Resources December 2025 resources expended 2025 Americsource8ergen E2-RadiatE 1,105 1,105 -1.105 -1.105 Atl At31 January In¢oming Resources December 2024 resources expended 2024 Americsource8ergen E2-RadiatE 36 -36 36 -36 AmericsourceBer8en Donations received to this fund are be applied for tunding SPECTA18iobank 15531 E2-RadlatE t>onatfjon5 recelved to this fund are be applied for fundlng E2-Radiate118111

Notes to the accounts 31 December 2025 8 Unre$trirted funds Ati At31 January Incoming Resouros December 2024 resources expended 2024 General funds Total unrestTlrted funds 17.836 17,836 53,731 53,731 -56.523 -56.523 15,044 15,044 Atl At31 January Incoming Resource5 D•¢ember 2024 resources expended 2024 General funds Total unrestrirted funds 19,771 19,771 40,086 40.086 42.021 -42,021 17,836 17,836